ProQR Therapeutics N.V. (PRQR)

NASDAQ: PRQR · Real-Time Price · USD

1.630

-0.030 (-1.81%)

At close: Oct 1, 2026, 4:00 PM EDT

1.640

+0.010 (0.61%)

Pre-market: Oct 2, 2026, 5:57 AM EDT

ProQR Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	230	213	273	161	264	570
Market Cap Growth	-2.49%	-22.19%	70.19%	-39.20%	-53.63%	170.61%
Enterprise Value	114	107	193	56	187	430
Last Close Price	1.63	2.02	2.65	1.98	3.70	8.01

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	10.93	11.09	13.52	22.05	56.74	210.75
PB Ratio	2.53	3.67	2.98	3.51	3.71	4.43
P/TBV Ratio	2.53	3.67	2.98	3.51	3.69	4.40
P/FCF Ratio	-	-	-	7.21	-	-
P/OCF Ratio	-	-	-	6.75	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	5.40	5.56	9.55	7.63	40.19	158.93
EV/FCF Ratio	-	-	-	2.49	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.19	0.32	0.19	0.48	0.33	0.53
Debt / FCF Ratio	-	-	-	0.98	-	-
Net Debt / Equity Ratio	-1.28	-1.55	-1.49	-2.40	-1.09	-1.12
Net Debt / EBITDA Ratio	2.43	1.80	4.47	2.91	1.13	2.25
Net Debt / FCF Ratio	2.03	1.42	3.50	-4.92	1.05	4.80
Asset Turnover	0.14	0.12	0.13	0.04	0.02	0.02
Quick Ratio	3.41	3.01	3.89	3.51	7.24	6.83
Current Ratio	3.49	3.09	3.96	3.54	7.36	6.94
Return on Equity (ROE)	-57.40%	-61.17%	-42.73%	-51.33%	-71.37%	-71.62%
Return on Assets (ROA)	-19.76%	-19.35%	-12.45%	-14.06%	-21.38%	-23.20%
Return on Capital Employed (ROCE)	-43.40%	-54.10%	-23.60%	-33.60%	-43.30%	-31.40%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-20.88%	-23.28%	-10.51%	-19.34%	-26.05%	-12.12%
FCF Yield	-24.53%	-29.69%	-14.31%	13.88%	-27.99%	-5.29%
Buyback Yield / Dilution	-8.75%	-22.36%	-6.26%	-13.08%	-11.62%	-28.21%

SEC Filings: 10-K · 10-Q